Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
delayed orgasm.
Popular Articles

Five Low Cost Ways To Prevent Cancer
In today"s troubled economy, saving money is a hot topic. No matter what gets cut from your budget, however, experts at The University of Texas M. D. Anderson Cancer Center believe that healthy choices to prevent cancer shouldn"t be on the list.
generic viagra
Smoking, High Blood Pressure And Diabetes In Mid-life Can Lead To Dementia
Middle aged people who smoke, have high blood pressure or diabetes are far more likely to develop dementia in later life, suggests research published ahead of print in the Journal of Neurology, Neurosurgery and Psychiatry.
News of the day
Duchenne Muscular Dystrophy, Lobbying Campaign At 10 Downing Street, UK
On 16 June, boys living with Duchenne Muscular Dystrophy, their families and supporters will be lobbying MPs and marching to No. 10 Downing Street to bring an end to the continuing serious under-funding for research into the condition. Results from recent clinical trials into the effectiveness of Exon Skipping as a gene therapy for the treatment of Duchenne have been very promising and scientists say that a cure is tantalisingly close, but more funding is needed. The lobby action is being organised by Action Duchenne, the only UK charity dedicated solely to raising awareness and raising funds for research into treatments and finding a cure, and providing support for families living with Duchenne.
Cardiovascular

Elron Group Company Medingo Receives Formal FDA Clearance To Market Its Insulin Micropump In The United States

Elron Electronic Industries Ltd. (NASDAQ & TASE: ELRN) announced, that further to it previous announcement on July 28, 2009, Medingo Ltd., a group company held 92% by Elron and its subsidiary, RDC - Rafael Development Corporation Ltd., has received formal clearance from the Food and Drug Administration ("FDA"), to market its Solo™ MicroPump Insulin Delivery System in the United States. Medingo intends to introduce the Solo™ MicroPump at the American Association of Diabetes Educators Meeting which will take place in August 2009 in Atlanta, U.S.A. "We are very excited to have received FDA clearance for Medingo"s innovative, miniature, tube-free, insulin delivery system," commented Arie Mientkavich, Chairman of Medingo and Elron. "This is a major milestone for Medingo, which will enable it to progress to the next phase in its development. Medingo is currently considering alternatives for its go-to-market strategy and the timing of the product launch." Elron Electronic Industries Ltd.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009